3663. Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial.
Lee K, Lee KH, Kim DW, Yoon J, Choi YJ, Lee S, Kim JW, Park KH, Choi W, Lee Y, Ryu H, Koo DH, Lee Y, Jeung HC, Lee MY, Lee N, Kang MJ, Lee J, Hong SH, Kang EJ, Park IH.
3662. Elimusertib, a Novel ATR Inhibitor, Induces Anti-Tumor Effects through Replication Catastrophe in Breast Cancers
Kim M, Min A, Kim S, Kim S, Kim YJ, Ham S, Lee M, Lee EY, Kim J, Lee DW, Lee KH, Im SA.
Cancer research and treatment [Epub ahead of print]Link
3661. Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers.
Woo S, Park PG, An T, Fatima M, Moon YE, Lee SY, Youn H, Hong KJ.
3656. Genome-scale knockout simulation and clustering analysis of drug-resistant breast cancer cells reveal drug sensitization targets
JinA Lim # 1, Hae Deok Jung # 1, Soo Young Park 2, Moonhyeon Jeon 1, Da Sol Kim 2, Ryeongeun Cho 1, Dohyun Han 3 4, Han Suk Ryu 2 5 6, Yoosik Kim 1 7 8 9, Hyun Uk Kim